Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Malignant Lymphoma

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    December 2011
  1. FIANCETTE R , Rouaud P, Vincent-Fabert C, Laffleur B, et al
    A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    J Immunol. 2011;187:5772-82.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  2. KIM J , Kim DW, Chang W, Choe J, et al
    Wnt5a Is Secreted by Follicular Dendritic Cells To Protect Germinal Center B Cells via Wnt/Ca2+/NFAT/NF-kappaB-B Cell Lymphoma 6 Signaling.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    September 2011
  3. MCPHEE CG , Sproule TJ, Shin DM, Bubier JA, et al
    MHC Class I Family Proteins Retard Systemic Lupus Erythematosus Autoimmunity and B Cell Lymphomagenesis.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  4. LASK A , Goichberg P, Cohen A, Goren-Arbel R, et al
    TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement.
    J Immunol. 2011;187:2006-14.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  5. ARITA K , Endo S, Kaifu T, Kitaguchi K, et al
    Transcriptional activation of the Pirb gene in B cells by PU.1 and Runx3.
    J Immunol. 2011;186:7050-9.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  6. BEDOGNETTI D , Zoppoli G, Massucco C, Zanardi E, et al
    Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin's Lymphoma Patients Treated with Rituximab-Containing Regimens.
    J Immunol. 2011.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  7. VAN GENT M , Griffin BD, Berkhoff EG, van Leeuwen D, et al
    EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection.
    J Immunol. 2011;186:1694-702.
    PubMed     Text format     Related articles    Abstract available



  8. O'REILLY MK , Tian H, Paulson JC
    CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.
    J Immunol. 2011;186:1554-63.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  9. FERNANDEZ A , Mesa C, Marigo I, Dolcetti L, et al
    Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.
    J Immunol. 2011;186:264-74.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  10. LEE H , Lee H, Kwon Y, Lee JH, et al
    Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells.
    J Immunol. 2010;185:6698-705.
    PubMed     Text format     Related articles    Abstract available



  11. MIGUEL RD , Cherpes TL, Watson LJ, McKenna KC, et al
    CTL induction of tumoricidal nitric oxide production by intratumoral macrophages is critical for tumor elimination.
    J Immunol. 2010;185:6706-18.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  12. SAITO TI , Li HW, Sykes M
    Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses.
    J Immunol. 2010;185:2099-105.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  13. HAYNES NM , Hawkins ED, Li M, McLaughlin NM, et al
    CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.
    J Immunol. 2010;185:532-41.
    PubMed     Text format     Related articles    Abstract available



    May 2010
  14. MERLO A , Turrini R, Bobisse S, Zamarchi R, et al
    Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    J Immunol. 2010;184:5895-902.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: